 
                        | Product NDC: | 0093-7305 | 
| Proprietary Name: | Mirtazapine | 
| Non Proprietary Name: | Mirtazapine | 
| Active Ingredient(s): | 45 mg/1 & nbsp; Mirtazapine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0093-7305 | 
| Labeler Name: | Teva Pharmaceuticals USA Inc | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA076901 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20050901 | 
| Package NDC: | 0093-7305-65 | 
| Package Description: | 10 BLISTER PACK in 1 BOX (0093-7305-65) > 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-7305-02) | 
| NDC Code | 0093-7305-65 | 
| Proprietary Name | Mirtazapine | 
| Package Description | 10 BLISTER PACK in 1 BOX (0093-7305-65) > 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-7305-02) | 
| Product NDC | 0093-7305 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Mirtazapine | 
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING | 
| Route Name | ORAL | 
| Start Marketing Date | 20050901 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Teva Pharmaceuticals USA Inc | 
| Substance Name | MIRTAZAPINE | 
| Strength Number | 45 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes |